|
Cyclodiode settings for rubeotic glaucoma
- 40 shots, 270 degrees, 1500mw 1500ms
- spare 3 and 9 o'clock and temporal position
- if pops, turn power lower
- this is far more laser than needed than non-rubeotic cases
- transilluminate ciliary body (in the dark)
to find it (shine the light form the opposite side of the eye)
- heel 1.5mm away from limbus in standard eye
- avoid pops and carbon on the probe
- lots of risks
- see glaucoma
for professionals
|
|
IVA (Avastin...Bevacizumab)
- is
very effective in reducing rubeosis see Avastin
- won't low the pressure if angle is blocked with fibrotic changes
(PAS)...cyclodiode is needed in addition
- if condition is caught early, use Avastin early. If vessels
are aggressive, do not wait for drops to work (drops alone are
usually not effective with significant rubeosis)
- drops...steroid and atropine
- lowering the pressure helps reduce the rubeosis
- in an eye that sees well consider early
tube surgery...Avastin
and drops whilst waiting.
|
|
Iliev
ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM.
Intravitreal bevacizumab (Avastin) in the treatment of neovascular
glaucoma.
Am J Ophthalmol. 2006 Dec;142(6):1054-6. Epub 2006 Aug 2. |
Gheith
ME, Siam GA, de Barros DS, Garg SJ, Moster MR.
Role of intravitreal bevacizumab in neovascular glaucoma.
J Ocul Pharmacol Ther. 2007 Oct;23(5):487-91. |
Vatavuk
Z, Bencic G, Mandic Z.
Intravitreal bevacizumab for neovascular glaucoma following central
retinal artery occlusion.
Eur J Ophthalmol. 2007 Mar-Apr;17(2):269-71. |
Kahook
MY, Schuman JS, Noecker RJ.
Intravitreal bevacizumab in a patient with neovascular glaucoma.
Ophthalmic Surg Lasers Imaging. 2006 Mar-Apr;37(2):144-6. |
Yazdani
S, Hendi K, Pakravan M.
Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
J Glaucoma. 2007 Aug;16(5):437-9. |
Grisanti
S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU;
Tuebingen Bevacizumab Study Group.
Intracameral bevacizumab for iris rubeosis.
Am J Ophthalmol. 2006 Jul;142(1):158-60. |
Chilov
MN, Grigg JR, Playfair TJ.
Bevacizumab (Avastin) for the treatment of neovascular glaucoma.
Clin Experiment Ophthalmol. 2007 Jul;35(5):494-6. |
Kelkar
AS, Kelkar SB, Kelkar JA, Nagpal M, Patil SP.
The use of intravitreal bevacizumab in neovascular glaucoma: a case
report.
Bull Soc Belge Ophtalmol. 2007;(303):43-5. |
Silva
Paula J, Jorge R, Alves Costa R, Rodrigues Mde L, Scott IU.
Short-term results of intravitreal bevacizumab (Avastin) on anterior
segment neovascularization in neovascular glaucoma.
Acta
Ophthalmol Scand. 2006 Aug;84(4):556-7 |
Oshima
Y, Sakaguchi H, Gomi F, Tano Y.
Regression of iris neovascularization after intravitreal injection
of bevacizumab in patients with proliferative diabetic retinopathy
Am
J Ophthalmol. 2006 Jul;142(1):155-8
|
